Cullinan Therapeutics (CGEM) Other Gross PP&E Adjustments (2020 - 2023)
Historic Other Gross PP&E Adjustments for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to -$2.9 million.
- Cullinan Therapeutics' Other Gross PP&E Adjustments rose 3494.22% to -$2.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$2.9 million, marking a year-over-year increase of 3494.22%. This contributed to the annual value of -$2.8 million for FY2022, which is 101294.5% down from last year.
- Cullinan Therapeutics' Other Gross PP&E Adjustments amounted to -$2.9 million in Q3 2023, which was up 3494.22% from -$3.5 million recorded in Q2 2023.
- Cullinan Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $309000.0 for Q4 2020, and its period low was -$4.5 million during Q3 2022.
- Its 4-year average for Other Gross PP&E Adjustments is -$2.1 million, with a median of -$2.8 million in 2022.
- In the last 5 years, Cullinan Therapeutics' Other Gross PP&E Adjustments plummeted by 101294.5% in 2022 and then skyrocketed by 3494.22% in 2023.
- Cullinan Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $309000.0 in 2020, then changed by 0.0% to $309000.0 in 2021, then plummeted by 1012.94% to -$2.8 million in 2022, then decreased by 3.69% to -$2.9 million in 2023.
- Its Other Gross PP&E Adjustments was -$2.9 million in Q3 2023, compared to -$3.5 million in Q2 2023 and -$3.8 million in Q1 2023.